Immunovant Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $412.5M
Liabilities Breakdown FY2021
Total Liabilities: $21.0M
Asset Breakdown
Total Assets: $412.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $400.1M | 97.0% |
| Accounts Receivable | $596.0K | 0.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $201.0K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $11.5M | 2.8% |
Liabilities Breakdown
Total Liabilities: $21.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.4M | 11.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $18.6M | 88.4% |